Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

Campi R., Brookman-May S. D. , Subiela Henriquez J. D. , AKDOĞAN B. , Brausi M., Klatte T., ...More

EUROPEAN UROLOGY FOCUS, vol.5, no.6, pp.1029-1057, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 5 Issue: 6
  • Publication Date: 2019
  • Doi Number: 10.1016/j.euf.2018.04.001
  • Title of Journal : EUROPEAN UROLOGY FOCUS
  • Page Numbers: pp.1029-1057


Context: To date, established risk factors for prostate cancer (PCa) are limited to age, race, family history, and certain genetic polymorphisms. Despite great research efforts, available evidence on potentially modifiable risk factors is conflicting. Moreover, most studies on PCa risk factors did not consider the impact of prostate-specific antigen (PSA) testing on PCa diagnosis.